Search Results 531-540 of 17550 for Assay

  1. Publications - Erinn Downs, D.O. - Mayo Clinic

    ... assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breast. Am J Surg Pathol. 2005 Nov; 29 (11):1505-11

  2. Diabetic Nephropathy Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the Renasight™ test, a next generation sequencing (NGS) gene mutation assay, for patients with chronic kidney ...

  3. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  4. Translating discoveries into therapeutics - Neurobiology of Parkinson's Disease and Related Disorders: Pam J. McLean

    ... assay to monitor oligomeric alpha-synuclein. Additional therapeutic discovery projects include developing a novel gene therapy to reduce alpha-synuclein ...

  5. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  6. Mayo Clinic develops neuro test that distinguishes demyelinating diseases from MS

    “We've collaborated with experts at Oxford University in MOG antibody testing to optimize our assay.” Both the MOG and AQP4 tests are available to Mayo ...

  7. Publications - Ashley R. Santilli, M.D. - Mayo Clinic

    Falsely Elevated Creatinine on Enzymatic Assay in a Patient Receiving Subcutaneous IgG Therapy. J Gen Intern Med. 2021 May; 36 (5):1427-1428 Epub 2021 Feb ...

  8. Clinical trials - Oncology (Medical)

    Rochester, Minn. The purpose of this study is to compare whether minimal residual disease (MRD) flow cytometric assay is not affected by different ...

  9. Hypoparathyroidism Clinical Trials - Mayo Clinic Research

    The purpose of this study is to collect patient samples to Ortho Clinical Diagnostics for evaluation of an in-development VITROS Intact PTH II assay and the ...

  10. Study Of Carboplatin And Mirvetuximab Soravtansine In First-Line Treatment Of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube Or Primary Peritoneal Cancer - Mayo Clinic

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...